胆管恶性肿瘤术前减黄研究进展  

Progress of research on preoperative biliary drainage for biliary malignant tumors

作　　者：邵子雨 吴文广 刘颖斌 SHAO Zi-yu;WU Wenguang;LIU Ying-bin(Department of General Surgery,Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200092,China;不详)

机构地区：[1]上海交通大学医学院附属新华医院普通外科,上海200127 [2]上海交通大学医学院附属仁济医院胆胰外科,上海200127

出　　处：《中国实用外科杂志》2020年第8期969-972,共4页Chinese Journal of Practical Surgery

基　　金：申康新兴前沿项目(No.SHDC12018107);上海交通大学医学院多中心临床研究项目(No.DLY201507,No.15ZH4003);上海市人工智能创新发展项目(No.沪经信智[2019]1014号)。

摘　　要：胆管恶性肿瘤因为位置的特殊性容易引起黄疸,影响病人的肝肾功能及预后。对于胆管癌引起的梗阻性黄疸病人,术前是否常规行胆道引流目前仍存争议。从近年来国内外对于术前减黄的必要性、适应证以及方式3个方面的研究进展来看,胆管癌是否行术前减黄不能一概而论,需要结合病人的胆红素水平、未来残余肝体积、年龄、营养状态等因素综合考虑。Biliary malignant tumors are prone to jaundice due to the specific location,affecting the liver and kidney function and prognosis of patients.For patients with obstructive jaundice caused by cholangiocarcinoma,it is still controversial whether routine preoperative biliary drainage is recommended.From the progress of research on the problem in recent years from the necessity,indications and methods of preoperative biliary drainage,the authors think that performing preoperative biliary drainage as routine in all patients is not rational.The total bilirubin level,volume of future liver remnant,age,nutritional status and other factors should be considered.

关 键 词：胆管癌 黄疸 胆道引流 

分 类 号：R6[医药卫生—外科学]